The anti-proliferative studies further demonstrated that activation of the hERG channel effectively impeded the growth of MDA-MB-231 cells from the TNBC cell line, whereas its inhibitory potency was significantly reduced in MCF-7 cells from the ER+ breast cancer cell line, indicating cell-line-specific difference in responses. Here, ESR1 is linked to breast carcinoma.